Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges
Popat Kumbhar, Arehalli S. Manjappa, Rohit Shah, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 1-15
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer
Wei Zheng, Tianchuan Zhu, Lantian Tang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Gabriele De Rubis, Keshav Raj Paudel, Leander Corrie, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2793-2833
Closed Access | Times Cited: 30
Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks
Popat Kumbhar, Kaustubh Kolekar, Sukriti Vishwas, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102322-102322
Closed Access | Times Cited: 14
Modified-Release Pulmonary Delivery Systems for Labile Bioactives: Design, Development, and Applications
Shivani Nana, Mershen Govender, Yahya E. Choonara
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 470-470
Open Access | Times Cited: 1
Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices
Devendra Birla, Nikhil Khandale, Bushra Bashir, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 6
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 451-451
Open Access | Times Cited: 16
Non‐Pore Dependent and MMP‐9 Responsive Gelatin/Silk Fibroin Composite Microparticles as Universal Delivery Platform for Inhaled Treatment of Lung Cancer
Shuangquan Gou, Gangyang Wang, Yanan Zou, et al.
Advanced Materials (2023) Vol. 35, Iss. 42
Closed Access | Times Cited: 16
Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro
Bikash Manandhar, Keshav Raj Paudel, Dvya Delilaa Clarence, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 343-356
Open Access | Times Cited: 15
Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy
Yu Tang, Lanfang Zhang, Rui Sun, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100833-100833
Open Access | Times Cited: 13
Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells
Gabriele De Rubis, Keshav Raj Paudel, Gang Liu, et al.
Toxicology in Vitro (2023) Vol. 92, pp. 105660-105660
Closed Access | Times Cited: 13
Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice
Y.X. Wang, Jing Zhang, Ying Liu, et al.
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 5
Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer
Popat Kumbhar, Kapil Kole, Varsha Khadake, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 812-830
Closed Access | Times Cited: 22
Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications
Popat Kumbhar, Kaustubh Kolekar, Chinmayee Khot, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 1150-1170
Closed Access | Times Cited: 19
Inhalation drug delivery in combating pulmonary infections: Advances and challenges
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105022-105022
Closed Access | Times Cited: 12
Diagnosing Orthotopic Lung Tumor Using a NTR-Activatable Near-Infrared Fluorescent Probe by Tracheal Inhalation
Jun Yan, Kaizhen Wang, Lijuan Gui, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 38, pp. 14402-14412
Closed Access | Times Cited: 11
Solid dispersions of bedaquiline fumarate to improve its pharmaceutical attributes: A comparative study between PEG and PVP
Vishwas P. Pardhi, Anchal Pathak, Keerti Jain
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105461-105461
Closed Access | Times Cited: 4
Weaponizing chitosan and its derivatives in the battle against lung cancer
Haitham Amin, Islam M. Ibrahim, Emad H.M. Hassanein
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132888-132888
Closed Access | Times Cited: 4
Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization
Seyedeh Negin Kassaee, Godwin A. Ayoko, Derek J. Richard, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 4
A nanotechnology driven effectual localized lung cancer targeting approaches using tyrosine kinases inhibitors: Recent progress, preclinical assessment, challenges, and future perspectives
Ankaj Kumar, Klaudi K. Vaiphei, Arvind Gulbake
International Journal of Pharmaceutics (2024), pp. 124745-124745
Closed Access | Times Cited: 4
Soluble starch nanoparticles loaded with Gefitinib for treating lung cancer: Optimization and cytotoxicity assessment
Mohammed A. Amin, Hamdoon A. Mohammed
International Journal of Biological Macromolecules (2025), pp. 140369-140369
Closed Access
Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road Ahead
Popat Kumbhar, Vikas Kamble, Kaustubh Kolekar, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Development and characterization of ethosomes of Acacia senegal for improved topical treatment of breast cancer
Sunil T. Galatage, Arehalli S. Manjappa, Kameswara Rao Sankula, et al.
Next Materials (2025) Vol. 8, pp. 100556-100556
Closed Access
RNA-lipid nanoparticle therapeutics for women’s health
Alireza Nomani, Aishwarya Saraswat, Yu Zhang, et al.
Frontiers in Nanotechnology (2025) Vol. 7
Open Access
Exosome‐Based Vaccines: Pioneering New Frontiers in Combating Infectious Diseases and Cancer
Xuejun Wang, Aixue Li, Ailing Wang, et al.
Small Methods (2025)
Closed Access
Page 1 - Next Page

Scroll to top